Drug for treating chronic obstructive emphysema

Abstract

The invention relates to a drug for treating chronic obstructive emphysema. The drug is prepared from, by weight, 10 parts of cortex lycii radicis, 15 parts of rhizoma atractylodis macrocephalae, 9 parts of rhizoma pinelliae, 10 parts of fewflower lysionotus herbs, 12 parts of herba ephedrae, 10 parts of herba pteridis multifidae, 15 parts of bulbus fritillariae ussuriensis, 9 parts of selfheal and 8 parts of fructus perillae. According to the drug, cortex lycii radicis can clear the lung to decrease internal fire; rhizoma atractylodis macrocephalae can strengthen the spleen, benefit Qi, eliminate dampness and promote urination; rhizoma pinelliae can eliminate dampness and dissipate phlegm; fewflower lysionotus herbs can clear heat and remove dampness; herba ephedrae can ventilate the lung, relieve asthma, promote urination and eliminate swelling; herba pteridis multifidae can clear heat and remove dampness; bulbus fritillariae ussuriensis can clear heat, moisten the lung, dissipate phlegm and relieve a cough; selheal can clear fire and remove stasis; fructus perillae can depress Qi and dissolve phlegm. All the traditional Chinese medicines are combined to jointly achieve the effects of nourishing Yin, moistening the lung, nourishing the spleen and strengthening the kidney to effectively treat the chronic obstructive emphysema. Clinical experiments prove that the drug can safely and effectively treat the chronic obstructive emphysema.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating chronic obstructive emphysema. Background technique [0002] Chronic obstructive emphysema is mostly caused by environmental pollution, smoking, infection factors, etc., which cause hyperinflation and expansion of the distal end of the lung terminal bronchi. [0003] The main symptom of the patient is dyspnea, which only occurs during physical labor in mild cases. As the degree of emphysema increases, the dyspnea gradually increases, and even occurs during rest. When combined with respiratory tract infection, the symptoms will be aggravated, and hypoxia, acidosis, etc. may occur. [0004] At present, Western medicine clinically treats chronic obstructive emphysema and mostly selects aminophylline, azithromycin, ciprofloxacin and other treatments. But treating the symptoms rather than the root cause can easily cause recurrent attacks of the disease. [0...

AI Technical Summary

Problems solved by technology

But treating the symptoms but not the root cause can easily lead to repeated attacks of the disease